Results 171 to 180 of about 83,566 (244)

Heterologous expression, immunogenic evaluation, and subunit vaccine potential of the σC protein from the Xinjiang avian reovirus (ARV) strain xj-1.1. [PDF]

Poult Sci
Li W, Qi Y, Ma X, Yang L, Dang X, Zuo Z, Zheng X, Zhang Y, Wang Y, Zhang S.   +9 more
europepmc   +1 more source

Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025

Pigment Cell &Melanoma Research, Volume 39, Issue 4, July 2026.
ABSTRACT The 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting took place in Amsterdam, The Netherlands on October 25th, 2025. Several promising drug candidates are in development; however, there is still an urgent need for better prevention, detection, and treatment of uveal melanoma.
Andrew E. Aplin, Katherina Alsina, Allison S. Betof, Joseph Birkett, Marcus O. Butler, George Cole Jr., Rizwan Haq, Florian A. Karreth, Vinit B. Mahajan, Rahul Marpadga, Prithvi Mruthyunjaya, Paul Nathan, Jonas A. Nilsson, Gary Palmer, Joseph J. Sacco, Takami Sato, Sarah Stanhope, Pang‐ning Teng, Kyleigh LiPira   +18 more
wiley   +1 more source

MecVax, an Epitope- and Structure-Based Broadly Protective Subunit Vaccine Against Enterotoxigenic <i>Escherichia coli</i> (ETEC). [PDF]

Microorganisms
Zhang W.
europepmc   +1 more source

The EBNA‐1 Conundrum: Does Epstein–Barr Virus Invoke Autoimmune Pathology in a Population Subset by Poorly Purine‐Loading Its Major Latency‐Maintaining Transcript?

Scandinavian Journal of Immunology, Volume 104, Issue 1, July 2026.
ABSTRACT Viruses activate host defences by alerting interferon and other alarms. Viruses seeking latency must curtail this. Infected subjects would then have minimal immune system activation and remain healthy. However, a minority cannot prevent emergence of associated diseases.
Donald R. Forsdyke
wiley   +1 more source

Vaccination with an African Swine Fever Virus Multiepitope Protein Chitosan Nanoparticle-Based Subunit Vaccine Elicits Robust Immune Responses In Vivo. [PDF]

Vaccines (Basel)
Lee CM, Suresh R, Boley PA, Shekoni OC, Schrock J, Dolatyabi S, Singh M, Khatiwada S, Yadav KK, Bugybayeva D, Hanson J, Gourapura RJ, Kenney SP.   +12 more
europepmc   +1 more source

Encapsulin‐Protected Immunotherapeutic Complexes: Bacteria‐Derived Nanoparticles for mRNA Delivery to Eukaryotic Cells

ChemMedChem, Volume 21, Issue 11, 15 June 2026.
Here, we introduce a biological, self‐assembling supramolecular nanoparticle designed to encapsulate eukaryotic‐expressible mRNA within an encapsulin shell via an encapsulin‐RNA adaptor peptide (ERAP). This process occurs in bacteria, and the resulting complex can deliver its mRNA into eukaryotic cells, where it is expressed.
Carlos Francisco Coffeen, Maribel Cayetano‐Cruz, Damaris Ilhuicatzi‐Alvarado, Carmen Méndez, Leticia Moreno‐Fierros, Ismael Bustos‐Jaimes   +5 more
wiley   +1 more source

The subunit vaccine of Lumpy skin disease virus elicits significant humoral and cell-mediated immune responses in mice. [PDF]

Front Vet Sci
Gu X, Deng X, Wu A, Li H, Liu Z, Wang W, Ma Z, Chen C.   +7 more
europepmc   +1 more source

Immunoinformatics-guided design of a universal chimeric multi-epitope subunit vaccine against Marburg virus disease and Ravn virus co-infection. [PDF]

Sci Rep
Ali S, Shah A, Khan S, Suleman M, Islam Z, Aleem MT.   +5 more
europepmc   +1 more source

Assessment of the Adjuvant Effects of Lentinan on the Tuberculosis Subunit Vaccine BG. [PDF]

Vaccines (Basel)
Zhou S, Hou Y, Zhang X, Lv Z, Hu Q, Yang X, Niu H.   +6 more
europepmc   +1 more source

Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors. [PDF]

Rheumatology (Oxford)
Källmark H, Gullstrand B, Kahn F, Grenmyr E, Kahn R, Einarsson JT, Bengtsson AA, Kapetanovic MC.   +7 more
europepmc   +1 more source